Medical Developments International Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MVP.AX research report →
Price Chart
About the company
Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations.
- CEO
- Brent MacGregor
- IPO
- 2003
- Employees
- 68
- HQ
- Scoresby, VIC, AU
Get TickerSpark's AI analysis on MVP.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $53.51M
- P/E
- 84.82
- Fwd P/E
- 36.54
- PEG
- -0.05
- P/S
- 1.26
- P/B
- 0.96
- EV/EBITDA
- 10.91
- Div Yield
- 0.00%
- Gross Margin
- 28.15%
- Op Margin
- 2.48%
- Net Margin
- 1.47%
- ROE
- 1.13%
- ROIC
- 1.68%
Latest fiscal year · YoY change
- Revenue
- $42.57M+9.0%
- Gross Profit
- $11.98M-59.3%
- Op Income
- $1.06M
- Net Income
- $626.00K+566.0%
- EPS
- $0.01+600.0%
- OCF Growth
- +13472.1%
- FCF Growth
- +1184.2%
- 52W High
- $0.77
- 52W Low
- $0.36
- 50D MA
- $0.43
- 200D MA
- $0.45
- Beta
- 1.41
- RSI (14)
- 54
- Avg Volume
- 193.94K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the MVP.AX Q4 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 86.8%
- Shares Outstanding
- 112.66M
- Float Shares
- 97.74M
Our MVP.AX coverage
Recent articles, reports, and earnings notes.
No research on MVP.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MVP.AX report →